Quality Assurance Programs



Beckman Coulter’s Hematology IQAP is a global peer comparison program available to users of Beckman Coulter Hematology systems.
 
Customers with Hematology instrumentation configured with Beckman Coulter reagents and using Beckman Coulter controls and calibrators are eligible for this free program. The Hematology IQAP program allows users of Coulter 6C Cell Control, Coulter 5C Cell Control, Coulter 4C Plus Cell Control, Coulter 4C ES Cell Control, AcT 5diff Control Plus, Coulter Retic-C Control, Coulter Retic-X Control and Coulter Body Fluid Control to obtain peer group comparison reports for their laboratory’s quality control data. Additionally, the Hematology IQAP program provides data entry forms and reports for Lin-C, Lin-X and Body Fluid Linearity Controls.
 
The benefits of Beckman Coulter’s Hematology Electronic Interlaboratory Quality Assurance Program (eIQAP) include:
  • Online submission of:
    • Daily control data
    • Monthly summary control data
    • Linearity control data
  • Fast online access to IQAP reports
  • Immediate access to previous IQAP reports
  • Reduction of paperwork
  • Management of corporate reports
  • Comparison with the largest hematology peer groups
Computer Requirements:


Go to Hematology eIQAP

Add login page to My Favorites

            

If you don’t have access, follow the easy steps below or click Help.

Register & Enroll in eIQAP

1) You must be registered on the Beckman Coulter website to eligible for access to the Electronic Quality Assurance Programs. If you already have a login ID, skip the registration and proceed to "Enroll in eIQAP" below.

2) Once you have a login ID, proceed to "Enroll in eIQAP" below.

Register now.

Forgot your login ID or password?
 
     Enroll in eIQAP 

In order to access the Hematology eIQAP program, you need to first set up your account.

We will guide you through the process step by step. You will need to have information regarding your institution and instruments handy to complete the process.

Enroll Me.